TipRanks
Go Ultimate55% OFF

Harel (HARL) AI Stock Analysis

Top Page

IL:HARL

Harel

(TASE:HARL)

Select Model
Rating:71Outperform
Price Target:ILA 21,846.00â–²(20.96% Upside)
Action:upgraded
Date:09/07/26

The score is driven primarily by improved profitability and strong ROE, tempered by rising leverage and uneven cash-flow generation. Technicals are constructive with price above key moving averages, though overbought signals add near-term risk. Valuation is supportive with a reasonable P/E and an attractive dividend yield.

Positive Factors
Improved Profitability and ROENet income reached ~3.0B in 2025 and ~3.3B TTM, while net margin expanded to ~9.8% and ~10.3%. This improvement indicates stronger earnings capacity and gives Harel more internal resources to support operations, absorb variability, and invest across its insurance and savings franchises.
Negative Factors
Rising LeverageDebt increased materially to ~26.4B TTM, lifting debt-to-equity to about 2.0x from ~1.23x in 2023. Higher leverage makes earnings and capital more sensitive to adverse underwriting or investment outcomes and reduces financial flexibility during stressed conditions.

Harel (HARL) vs. iShares MSCI Israel ETF (EIS)

-20%0%20%40%60%80%IL:HARL+55.13%EIS+13.14%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
ILS 37.10B
Dividend Yield
3.85%
Average Volume (3M)
308.77K
Price to Earnings (P/E)
11.3
Beta (1Y)
1.47
Revenue Growth
14.74%
EPS Growth
70.44%
Country
Israel
Employees
5,000
Sector
General
Sector Strength
55
Industry
Insurance - Diversified

Harel Business Overview & Revenue Model

Company Description

Harel Insurance Investments & Financial Services Ltd, established in 1933 and headquartered in Ramat Gan, Israel, is a leading provider of insurance and financial products operating across Israel, the United States, and Western Europe. The company st...

How the Company Makes Money

Harel makes money primarily through: (1) Insurance operations: It earns insurance revenue from policyholders in the form of premiums for life, health, and general (property & casualty) insurance products. Profitability in these lines is driven by und...

Harel Financial Statement Overview

Summary

Profitability rebounded strongly into 2025 and TTM with higher net income, expanding margins, and very strong ROE (~25%). Offsetting this, leverage has risen materially (debt-to-equity ~2.0x TTM) and cash-flow quality is volatile, including negative operating/free cash flow in 2024 and softer TTM free cash flow versus 2025.

Income Statement

78Positive

Balance Sheet

63Positive

Cash Flow

52Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue30.83B30.63B27.16B24.86B12.69B27.49B
Gross Profit30.50B30.63B24.73B24.86B10.70B25.68B
EBITDA6.47B5.02B2.45B1.53B2.06B2.31B
Net Income3.28B2.99B946.00M485.00M906.00M1.21B
Balance Sheet
Total Assets174.17B163.63B158.66B144.81B135.27B137.67B
Cash, Cash Equivalents and Short-Term Investments31.30B2.74B25.53B26.50B24.89B26.25B
Total Debt26.39B22.27B18.50B10.95B7.28B7.14B
Total Liabilities161.51B151.44B149.46B135.85B126.88B128.78B
Stockholders Equity12.63B12.17B9.12B8.89B8.34B8.86B
Cash Flow
Free Cash Flow2.24B5.43B-3.52B3.02B1.60B1.13B
Operating Cash Flow2.64B5.47B-3.06B3.47B1.98B1.49B
Investing Cash Flow-462.00M-514.00M-1.02B-511.00M-371.00M-632.00M
Financing Cash Flow-1.85B-1.45B1.45B1.01B-1.01B581.00M

Harel Technical Analysis

Technical Analysis SentimentNegative
Last Price18060.00

Price Trends

50DMA19040.02Negative
100DMA17749.71Positive
200DMA17053.67Positive

Market Momentum

MACD-65.55Positive
RSI37.72Neutral
STOCH19.16Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:HARL, the sentiment is Negative. The current price of 18060.00 is below the 20-day moving average (MA) of 19087.00, below the 50-day MA of 19040.02, and above the 200-day MA of 17053.67, indicating a neutral trend. The MACD of -65.55 indicates Positive momentum. The RSI at 37.72 is Neutral, neither overbought nor oversold. The STOCH value of 19.16 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:HARL.

Harel Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IL:HARL against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IL:IDINIL:IDIN80OutperformILS 3.69B9.99―7.59%3.98%14.95%
IL:MMHDIL:MMHD77OutperformILS 30.86B12.32―3.24%18.14%49.80%
IL:PHOEIL:PHOE75OutperformILS 42.92B12.94―3.25%10.88%24.40%
IL:HARLIL:HARL71OutperformILS 37.11B11.3223.23%3.85%14.74%70.44%
IL:AYALIL:AYAL66NeutralILS 4.70B9.93―2.83%――
IL:CLISIL:CLIS65NeutralILS 21.75B9.05―1.84%-30.50%67.45%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

0%50%100%150%IL:HARLIL:CLISIL:PHOEIL:MMHDIL:AYALIL:IDINDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
IL:HARL and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IL:HARLHarel Insurance Investments & Financial Services 18060.007109.6164.93%
IL:CLISClal Insurance Enterprises Holdings 26900.009065.4650.83%
IL:PHOEPhoenix Holdings Ltd.17000.004809.4839.45%
IL:MMHDMenora Mivtachim Holdings Ltd.49390.0018067.1757.68%
IL:AYALAyalon Holdings Ltd.16580.009945.78149.92%
IL:IDINI.D.I. Insurance Company Ltd.24950.006556.5735.65%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 07, 2026